Jump to Main Content
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
- Ferreira, Vitor, Grajales, Diana, Valverde, Ángela M.
- Biochimica et biophysica acta 2020 v.1865 no.2 pp. 158534
- adipocytes, adipose tissue, adverse effects, antipsychotics, hyperglycemia, hyperlipidemia, lipid metabolism, patients, schizophrenia, weight gain
- Schizophrenia is a neuropsychiatric disorder that chronically affects 21 million people worldwide. Second-generation antipsychotics (SGAs) are the cornerstone in the management of schizophrenia. However, despite their efficacy in counteracting both positive and negative symptomatology of schizophrenia, recent clinical observations have described an increase in the prevalence of metabolic disturbances in patients treated with SGAs, including abnormal weight gain, hyperglycemia and dyslipidemia. While the molecular mechanisms responsible for these side-effects remain poorly understood, increasing evidence points to a link between SGAs and adipose tissue depots of white, brown and beige adipocytes. In this review, we survey the present knowledge in this area, with a particular focus on the molecular aspects of adipocyte biology including differentiation, lipid metabolism, thermogenic function and the browning/beiging process.